Treatment outcomes and prognostic factors of medication-related osteonecrosis of the jaw: a case- and literature-based review. 2019

Shin-Ichi Yamada, and Hiroshi Kurita, and Eiji Kondo, and Shigeru Suzuki, and Fumihiro Nishimaki, and Nobuhiko Yoshimura, and Masafumi Morioka, and Shutaro Ishii, and Takahiro Kamata
Department of Dentistry and Oral Surgery, Shinshu University School of Medicine, 3-1-1, Asahi, Matsumoto, 390-8621, Japan. yshinshin@shinshu-u.ac.jp.

OBJECTIVE The purpose of this study was to investigate the treatment outcomes and prognostic factors of medication-related osteonecrosis of the jaw (MRONJ) in Japanese patients. METHODS Among 409 cases, treatment outcomes and prognostic factors were investigated in 275 patients. In statistical analyses, the 1-year cumulative curative rate was calculated with the Kaplan-Meier method, and significance was examined with the Wilcoxon test. Cox's proportional hazards regression analysis was used for the multivariate analysis. RESULTS Resolution of the disease was achieved in 137 out of 275 MRONJ patients (49.8%). One-year cumulative curative rates were 39.8% in stage 1 patients, 26.3% in stage 2, and 19.0% in stage 3. The 1-year cumulative curative rates of treatment interventions were 17.2% for conservative treatment, 34.5% for sequestrectomy, and 40.7% for extended surgery including bone resection and segmental resection. As the prognostic factors of treatment outcomes, the type of medication, stage of MRONJ, and type of surgical intervention were identified as independent factors in a multivariate analysis. CONCLUSIONS These results suggest that surgical interventions may lead to a good prognosis in MRONJ patients. CONCLUSIONS This study indicated that surgical intervention for MRONJ might lead to improvement of prognosis and quality of life in MRONJ patients.

UI MeSH Term Description Entries
D007568 Jaw Bony structure of the mouth that holds the teeth. It consists of the MANDIBLE and the MAXILLA. Jaws
D008297 Male Males
D011379 Prognosis A prediction of the probable outcome of a disease based on a individual's condition and the usual course of the disease as seen in similar situations. Prognostic Factor,Prognostic Factors,Factor, Prognostic,Factors, Prognostic,Prognoses
D011788 Quality of Life A generic concept reflecting concern with the modification and enhancement of life attributes, e.g., physical, political, moral, social environment as well as health and disease. HRQOL,Health-Related Quality Of Life,Life Quality,Health Related Quality Of Life
D005260 Female Females
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D016896 Treatment Outcome Evaluation undertaken to assess the results or consequences of management and procedures used in combating disease in order to determine the efficacy, effectiveness, safety, and practicability of these interventions in individual cases or series. Rehabilitation Outcome,Treatment Effectiveness,Clinical Effectiveness,Clinical Efficacy,Patient-Relevant Outcome,Treatment Efficacy,Effectiveness, Clinical,Effectiveness, Treatment,Efficacy, Clinical,Efficacy, Treatment,Outcome, Patient-Relevant,Outcome, Rehabilitation,Outcome, Treatment,Outcomes, Patient-Relevant,Patient Relevant Outcome,Patient-Relevant Outcomes
D050071 Bone Density Conservation Agents Agents that inhibit BONE RESORPTION and/or favor BONE MINERALIZATION and BONE REGENERATION. They are used to heal BONE FRACTURES and to treat METABOLIC BONE DISEASES such as OSTEOPOROSIS. Antiresorptive Agent,Antiresorptive Agents,Antiresorptive Drugs,Bone Resorption Inhibitors,Bone Resorption Inhibitory Agents,Agent, Antiresorptive,Inhibitors, Bone Resorption,Resorption Inhibitors, Bone
D059266 Bisphosphonate-Associated Osteonecrosis of the Jaw Necrotic jaws or other maxillofacial skeleton necrosis associated with bisphosphonate use (see BISPHOSPHONATES). Injury, dental procedures, and trauma can trigger the necrotic process. Bisphosphonate Osteonecrosis,Bisphosphonate-Associated Osteonecrosis,Bisphosphonate-Associated Osteonecrosis of the Jaws,Bisphosphonate-Induced Osteonecrosis of the Jaw,Bisphosphonate-Induced Osteonecrosis of the Jaws,Bisphosphonate-Related Osteonecrosis of the Jaw,Osteonecrosis of the Jaw, Bisphosphonate-Associated,Osteonecrosis of the Jaw, Bisphosphonate-Induced,Osteonecrosis of the Jaw, Bisphosphonate-Related,Osteonecrosis of the Jaws, Bisphosphonate-Associated,Osteonecrosis of the Jaws, Bisphosphonate-Induced,Osteonecrosis of the Jaws, Bisphosphonate-Related,Bisphosphonate Associated Osteonecrosis,Bisphosphonate Associated Osteonecrosis of the Jaw,Bisphosphonate Associated Osteonecrosis of the Jaws,Bisphosphonate Induced Osteonecrosis of the Jaw,Bisphosphonate Induced Osteonecrosis of the Jaws,Bisphosphonate Osteonecroses,Bisphosphonate Related Osteonecrosis of the Jaw,Bisphosphonate-Associated Osteonecroses,Osteonecroses, Bisphosphonate,Osteonecroses, Bisphosphonate-Associated,Osteonecrosis of the Jaw, Bisphosphonate Associated,Osteonecrosis of the Jaw, Bisphosphonate Induced,Osteonecrosis of the Jaw, Bisphosphonate Related,Osteonecrosis of the Jaws, Bisphosphonate Associated,Osteonecrosis of the Jaws, Bisphosphonate Induced,Osteonecrosis of the Jaws, Bisphosphonate Related,Osteonecrosis, Bisphosphonate,Osteonecrosis, Bisphosphonate-Associated

Related Publications

Shin-Ichi Yamada, and Hiroshi Kurita, and Eiji Kondo, and Shigeru Suzuki, and Fumihiro Nishimaki, and Nobuhiko Yoshimura, and Masafumi Morioka, and Shutaro Ishii, and Takahiro Kamata
April 2024, Clinical case reports,
Shin-Ichi Yamada, and Hiroshi Kurita, and Eiji Kondo, and Shigeru Suzuki, and Fumihiro Nishimaki, and Nobuhiko Yoshimura, and Masafumi Morioka, and Shutaro Ishii, and Takahiro Kamata
June 2019, Journal of oral biosciences,
Shin-Ichi Yamada, and Hiroshi Kurita, and Eiji Kondo, and Shigeru Suzuki, and Fumihiro Nishimaki, and Nobuhiko Yoshimura, and Masafumi Morioka, and Shutaro Ishii, and Takahiro Kamata
February 2020, Orvosi hetilap,
Shin-Ichi Yamada, and Hiroshi Kurita, and Eiji Kondo, and Shigeru Suzuki, and Fumihiro Nishimaki, and Nobuhiko Yoshimura, and Masafumi Morioka, and Shutaro Ishii, and Takahiro Kamata
February 2020, Journal of stomatology, oral and maxillofacial surgery,
Shin-Ichi Yamada, and Hiroshi Kurita, and Eiji Kondo, and Shigeru Suzuki, and Fumihiro Nishimaki, and Nobuhiko Yoshimura, and Masafumi Morioka, and Shutaro Ishii, and Takahiro Kamata
September 2022, Genesis (New York, N.Y. : 2000),
Shin-Ichi Yamada, and Hiroshi Kurita, and Eiji Kondo, and Shigeru Suzuki, and Fumihiro Nishimaki, and Nobuhiko Yoshimura, and Masafumi Morioka, and Shutaro Ishii, and Takahiro Kamata
July 2022, Clinical medicine (London, England),
Shin-Ichi Yamada, and Hiroshi Kurita, and Eiji Kondo, and Shigeru Suzuki, and Fumihiro Nishimaki, and Nobuhiko Yoshimura, and Masafumi Morioka, and Shutaro Ishii, and Takahiro Kamata
July 2022, Clinical medicine (London, England),
Shin-Ichi Yamada, and Hiroshi Kurita, and Eiji Kondo, and Shigeru Suzuki, and Fumihiro Nishimaki, and Nobuhiko Yoshimura, and Masafumi Morioka, and Shutaro Ishii, and Takahiro Kamata
August 2018, Journal of the Korean Association of Oral and Maxillofacial Surgeons,
Shin-Ichi Yamada, and Hiroshi Kurita, and Eiji Kondo, and Shigeru Suzuki, and Fumihiro Nishimaki, and Nobuhiko Yoshimura, and Masafumi Morioka, and Shutaro Ishii, and Takahiro Kamata
December 2019, European review for medical and pharmacological sciences,
Shin-Ichi Yamada, and Hiroshi Kurita, and Eiji Kondo, and Shigeru Suzuki, and Fumihiro Nishimaki, and Nobuhiko Yoshimura, and Masafumi Morioka, and Shutaro Ishii, and Takahiro Kamata
February 2020, Cureus,
Copied contents to your clipboard!